Anticancer agent 215

Anticanceragent 215 is a potent camptothecin-based compound demonstrating nanomolar cytotoxicity against breast cancer cell lines MCF-7 and MDA-MB-231. This small molecule is a valuable research tool for investigating topoisomerase I inhibition and evaluating antitumor efficacy in both in vitro and in vivo cancer models.